Beispiel: Heart Attack

Klinische Studien gesponsert von Alimera Sciences

Insgesamt 11 ergebnisse

NCT04469595

Rekrutierung

A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME)

Bedingungen: Diabetic Macular Edema
NCT02472366

Abgeschlossen

A Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Corticosteroid Therapy

Bedingungen: Chronic Diabetic Macular Edema
NCT02424019

Unbekannter Status

Phase 4 IOP Signals Associated With ILUVIEN®

Bedingungen: Diabetic Macular Edema (DME)
NCT02080091

Beendet

Observational Study to Assess the Effect of Iluvien® in DME Patients Insufficiently Responsive to Available Therapies

Bedingungen: Diabetic Macular Edema (DME)
NCT01998412

Aktiv, nicht rekrutierend

Iluvien Registry Safety Study

Bedingungen: Chronic Diabetic Macular Oedema Considered Insufficiently Responsive to Available Therapies
NCT01304706

Abgeschlossen

Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension Study

Bedingungen: Diabetic Macular Edema
NCT00770770

Beendet

Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina

Bedingungen: Macular Edema; Retinal Vein Occlusion
NCT00695318

Beendet

Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy

Bedingungen: Age-Related Macular Degeneration
NCT00490815

Abgeschlossen

Pharmacokinetic and Efficacy Study of Fluocinolone Acetonide Inserts in Patients With Diabetic Macular Edema

Bedingungen: Diabetic Macular Edema
NCT00344968

Abgeschlossen

Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema

Bedingungen: Diabetic Macular Edema
NCT00605423

Abgeschlossen

The MAP Study: Fluocinolone Acetonide (FA)/Medidur (TM) for Age Related Macular Degeneration (AMD) Pilot

Bedingungen: Age Related Macular Degeneration